• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认识到慢性肾脏病与心血管疾病之间的联系。

Recognizing the link between chronic kidney disease and cardiovascular disease.

机构信息

Division of Nephrology, University of Maryland, School of Medicine, Baltimore, MD, USA.

出版信息

Am J Manag Care. 2011 Dec;17 Suppl 15:S396-402.

PMID:22214474
Abstract

The prevalence of chronic kidney disease (CKD) is rising in the United States, and cardiovascular disease (CVD) is increasingly recognized to occur at elevated rates in patients with CKD compared with the general population. The impact of CVD in patients with CKD is significant, inversely related to the level of kidney function, and exaggerated when compared with matched patients without CKD. CKD is associated with an increased risk of CVD, CVD events, and death, but the prevalence of traditional CVD risk factors is also increased compared with the general population. Proteinuria, hypertension, dyslipidemia, and diabetes are common in patients with CKD and contribute directly to CVD events. CKD-related factors (eg, disorders of electrolyte and mineral metabolism, anemia, and vascular calcification) also contribute to mortality associated with CKD.

摘要

在美国,慢性肾脏病(CKD)的患病率正在上升,人们越来越认识到,与普通人群相比,CKD 患者的心血管疾病(CVD)发病率更高。CKD 患者的 CVD 影响重大,与肾功能水平呈反比,与匹配的无 CKD 患者相比则被夸大。CKD 与 CVD、CVD 事件和死亡风险增加相关,但与普通人群相比,传统 CVD 风险因素的患病率也有所增加。蛋白尿、高血压、血脂异常和糖尿病在 CKD 患者中很常见,直接导致 CVD 事件。CKD 相关因素(如电解质和矿物质代谢紊乱、贫血和血管钙化)也与 CKD 相关的死亡率有关。

相似文献

1
Recognizing the link between chronic kidney disease and cardiovascular disease.认识到慢性肾脏病与心血管疾病之间的联系。
Am J Manag Care. 2011 Dec;17 Suppl 15:S396-402.
2
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).慢性肾脏病3期和4期患者的血浆甲状旁腺激素水平与心血管疾病患病率:来自肾脏早期评估项目(KEEP)的分析
Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10. doi: 10.1053/j.ajkd.2008.11.029.
3
[Epidemiology of cardiovascular disease in CKD-MBD].[慢性肾脏病矿物质和骨异常中的心血管疾病流行病学]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 49:S3-10.
4
Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter.慢性肾脏病患者的心血管疾病:问题的核心
Am J Kidney Dis. 2001 Dec;38(6):1398-407. doi: 10.1053/ajkd.2001.29275.
5
[Cardiovascular system in patients in different stages of chronic kidney disease].[慢性肾脏病不同阶段患者的心血管系统]
Pol Merkur Lekarski. 2006 Aug;21(122):125-9; discussion 130-1.
6
Optimizing outcomes in patients with cardiovascular disease and chronic kidney disease.优化心血管疾病和慢性肾脏病患者的治疗效果。
Am J Manag Care. 2011 Dec;17 Suppl 15:S403-11.
7
Management of cardiovascular disease in chronic kidney disease: implications for managed care.慢性肾脏病中的心血管疾病管理:对管理式医疗的影响。
Am J Manag Care. 2011 Dec;17 Suppl 15:S412-8.
8
Chronic kidney disease and cardiovascular disease: a case presentation.慢性肾脏病与心血管疾病:病例报告
Nephrol Nurs J. 2007 Mar-Apr;34(2):187-98; quiz 199-200.
9
Cardiovascular disease in children with chronic renal failure.慢性肾衰竭患儿的心血管疾病
Growth Horm IGF Res. 2006 Jul;16 Suppl A:S84-90. doi: 10.1016/j.ghir.2006.03.014. Epub 2006 May 15.
10
The epidemic of chronic kidney disease: looking at ageing and cardiovascular disease through kidney-shaped lenses.慢性肾脏病的流行:从“肾脏形状的镜片”看老龄化和心血管疾病。
J Intern Med. 2010 Nov;268(5):449-55. doi: 10.1111/j.1365-2796.2010.02289.x.

引用本文的文献

1
Chronic Kidney Disease and Arterial Stiffness: A Two-Way Path.慢性肾脏病与动脉僵硬度:一条双向通路。
Front Med (Lausanne). 2021 Nov 23;8:765924. doi: 10.3389/fmed.2021.765924. eCollection 2021.
2
Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification.血管壁中肌肉抑制素/激活素-A 信号转导与血管钙化。
Cells. 2021 Aug 12;10(8):2070. doi: 10.3390/cells10082070.
3
Potential Role of H-Ferritin in Mitigating Valvular Mineralization.铁蛋白 H 在减轻瓣膜矿化中的潜在作用。
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):413-431. doi: 10.1161/ATVBAHA.118.312191.
4
Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan.在慢性肾脏病患者中,使用经处方的肾脏保护类中草药与全因死亡率和特定疾病死亡率的降低相关:一项基于台湾人群的随访研究。
Evid Based Complement Alternat Med. 2017;2017:5632195. doi: 10.1155/2017/5632195. Epub 2017 Jul 17.
5
Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure.实验性肾衰竭期间肾钙和磷转运失调
PLoS One. 2015 Nov 13;10(11):e0142510. doi: 10.1371/journal.pone.0142510. eCollection 2015.
6
Assessment of physical activity in patients with chronic kidney disease and renal replacement therapy.慢性肾脏病患者及肾脏替代治疗患者的体力活动评估
Springerplus. 2015 Sep 21;4(1):536. doi: 10.1186/s40064-015-1338-3. eCollection 2015.
7
Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury.通过激活 Nrf2-ARE 信号通路对氧化应激诱导的心血管和肾脏损伤的 MG132 的预防和治疗作用。
Oxid Med Cell Longev. 2013;2013:306073. doi: 10.1155/2013/306073. Epub 2013 Mar 7.
8
Vascular calcification in diabetes: mechanisms and implications.糖尿病血管钙化:机制与意义。
Curr Diab Rep. 2013 Jun;13(3):391-402. doi: 10.1007/s11892-013-0379-7.
9
Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.慢性肾脏病血管钙化的消退——可行还是幻想?临床证据的综述。
Br J Clin Pharmacol. 2013 Oct;76(4):560-72. doi: 10.1111/bcp.12014.